Master of Science in Biomedical Communications Program

Jodie Jenkinson et Nick Woolridge de MScBMC à propos de l'image emblématique SARS-CoV-2, et la réalisation d'une vue en coupe pour révéler son intérieur. "D’où vient l’image emblématique du nouveau coronavirus?"

Obtenez toute l'histoire. https://bit.ly/3csiHWv

Jodie Jenkinson and Nicholas Woolridge of MScBMC on the iconic SARS-CoV-2 image, and on making a cutaway to reveal the virus' interior. "D’où vient l’image emblématique du nouveau coronavirus?"

Get the whole story. https://bit.ly/3csiHWv








-CoV-2 -19 Communications @ University of Toronto Mississauga

Medical illustrators: an essential source of information during the pandemic. CBC Radio story with MScBMC's Nick Woolridge, alumna Kate Campbell, and student Jennifer Barolet. https://bit.ly/2yo0hYY

Les illustrateurs médicaux: source d’information indispensable pendant la pandémie. Histoire de CBC Radio avec: MScBMC's Nick Woolridge, diplômé Kate Campbell, et étudiant Jennifer Barolet. https://bit.ly/2zW1JC0 .

Repurposing approved drugs to treat SARS-CoV-2
A team of applied scientists led by Vijay Shahani (MScBMC 1T5) has identified thousands of small molecule drugs that can potentially be repurposed to target the SARS-CoV-2 virus that causes COVID-19.
Get the whole story: UofT.me/potential-SARSCOV2-therapies
Photo: Dr. Vijay Shahani, Head of Applied Science at Cyclica Inc.
Visualization: Cyclica’s AI technology predicts that the drug disopyramide will interact with the human protein TMPRSS2 involved in SARS-CoV-2 infection.

exec



@ University of Toronto Mississauga